MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    Waiting and waiting on Dopamine transporter imaging in drug induced parkinsonism

    JY. Yun, CY. Lee, MY. Chun, B. Jeon (Seoul, Republic of Korea)

    Objective: We discontinued offending medications in DIP or unmasked parkinsonism patients and delayed taking DAT images for one month. Background: Drug induced parkinsonism (DIP) may…
  • 2019 International Congress

    Parkinson’s Panorama: Epidemiology and Non-motor Symptoms, Revisiting Taboo Topic of Sexual Dysfunction in a Malaysian Parkinson’s Population

    Y Y. Tan, K. Tan (Georgetown, Malaysia)

    Objective: There is limited data on sexual dysfunction as an non-motor symptom (NMS) in Parkinson’s, especially in most developing countries in Asia where the discussion…
  • 2019 International Congress

    Validation of a novel quotient differentiating cognitive and motor-driven activity of daily living impairments in PD patients

    S. Becker, C. Pauly, M. Lawton, G. Hipp, F. Bowring, P. Sulzer, M. Hu, R. Krüger, I. Liepelt-Scarfone (Tübingen, Germany)

    Objective: To validate novel scores assessing cognitive-driven activity of daily living (ADL) dysfunction in a large, international pooled non-demented Parkinson’s disease (PD) cohort. Background: The…
  • 2019 International Congress

    Computerized cognitive test profile of 100 patients with and without Amyloid beta 1-42 burden

    F. Waga, I. Liepelt-Scarfone, M. Bentele, W. Maetzler, S. Becker, M. Timmers, L. van Nueten, G. Salvadore, K. Brockmann, M. Hobert, J. Streffer, D. Berg (Titusville, NJ, USA)

    Objective: To investigate whether a computerized neuropsychological assessment can detect subtle cognitive impairment associated with Aβ pathology in Parkinson’s disease (PD). Background: Parenchymal Aβ pathology…
  • 2019 International Congress

    Neuropsychological differences between patients with Parkinson’s Disease and Essential Tremor

    M. Zorn, K. Duff, J. Rolston, C. Aquino, J. Ballard, P. Moretti (Salt Lake City, UT, USA)

    Objective: Investigate neuropsychological differences between Parkinson's disease (PD) and essential tremor (ET) patients presenting for evaluation for Deep Brain Stimulation (DBS) surgery. Background: Although patients with PD and ET have…
  • 2019 International Congress

    Weighting fibroblasts for future diagnostic prospect

    G. Prevot, E. Bezard, L. Cognet, B. Dehay, P. Bon (Bordeaux, France)

    Objective: To determine the dry mass of fibroblasts obtained from apparently healthy individuals and patients with brain disorders or cancer pathologies for future diagnosis prospect.…
  • 2019 International Congress

    Inflammatory Conditions in Parkinson’s Disease

    B. Krishnamachari, S. Shermon, M. Goldfinger, A. Leder, B. Harper, J. Donoghue (Old Westbury, NY, USA)

    Objective: The goal was to conduct a case-control study to assess associations between Parkinson disease (PD) and inflammatory conditions including allergies, asthma, eczema, atopic conditions,…
  • 2019 International Congress

    Prevalence of Parkinson’s disease in a district of central highlands of Peru: Preliminary report

    E. Sarapura-Castro, K. Milla-Neyra, S. Montano, I. Mata, M. Inca-Martinez, J. Rios-Pinto, C. Cosentino, P. Mazzetti, M. Cornejo-Olivas (Lima, Peru)

    Objective: To  determine the prevalence of Parkinson disease in a district of central highlands of Peru Background: The overall  prevalence of PD among adults worldwide…
  • 2019 International Congress

    Unscheduled disruption of Deep Brain Stimulation (DBS) in Parkinson’s Disease (PD)

    A. Blain, O. Lagha-Boukbiza, O. Gebus, M. Anheim, C. Tranchant (Strasbourg, France)

    Objective: This is a descriptive study about consequences and management of unscheduled DBS disruption in 12 PD patients. Background: Unscheduled DBS disruption may  occur mainly…
  • 2019 International Congress

    Metabolic Surgery in the adjuvant management of Parkinson’s Disease

    C. Jauregui Pasache, W. Kunz Martínez, A. Pérez Pacheco (Querétaro, Mexico)

    Objective: To explore the effect of metabolic surgery (Bipartition of Intestinal Transit) on Parkinson's Disease (PD). To compare the effects observed with those presented in…
  • « Previous Page
  • 1
  • …
  • 185
  • 186
  • 187
  • 188
  • 189
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley